NLS Pharmaceutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 134%.

Top 13 shareholders own 30.77% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
7.57%	BVF Partners L.P.	143,676	US$492.8k	0%	0.01%
5.66%	Felix Grisard	107,366	US$368.3k	32.4%	no data
4.61%	The Lind Partners, LLC	87,500	US$300.1k	0%	2.08%
3.75%	Magnetic Rock Investment AG	71,125	US$244.0k	0%	no data
2.73%	Ronald Hafner	51,793	US$177.6k	0%	no data
2.11%	Alexander Zwyer	39,953	US$137.0k	0%	no data
1.8%	George Apostol	34,098	US$117.0k	0%	no data
1.45%	Eric Konofal	27,591	US$94.6k	0%	no data
0.35%	Gian-Marco de la Cruz	6,718	US$23.0k	0%	no data
0.33%	Alpha Capital Anstalt	6,175	US$21.2k	0%	0.19%
0.25%	UBS Asset Management AG	4,719	US$16.2k	-19.9%	no data
0.13%	Quorus Vermögensverwaltung AG	2,500	US$8.6k	0%	no data
0.033%	Herve Girsault	625	US$2.1k	0%	no data